DermTech, Inc.
DMTK · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5.4% | 22.6% | 101.2% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 1.8% | 4.5% | 10.8% | -1.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -640% | -763.8% | -634.4% | -591.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -659.6% | -803.7% | -661.7% | -619.8% |
| EPS Diluted | -3.09 | -3.88 | -2.71 | -2.05 |
| % Growth | 20.4% | -43.2% | -32.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |